SR1664

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
012320112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Thiazolidinediones (TZD) function as potent anti-diabetic drugs through their direct action on the nuclear receptor peroxisome… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
The nuclear receptor PPARγ regulates adipogenesis and plays a central role in lipid and glucose homeostasis, and is the molecular… (More)
Is this relevant?
2016
2016
The peroxisome proliferator-activated receptor γ (PPARγ) ligands are important therapeutic drugs for the treatment of type 2… (More)
  • figure 1
  • figure 3
  • figure 3
  • table 1
  • table 2
Is this relevant?
2015
2015
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is the master regulator of adipogenesis and the… (More)
Is this relevant?
2015
2015
Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor family and plays key roles in glucose… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor gamma (PPARγ) agonists that improve insulin resistance… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Thiazolidinedione class of anti-diabetic drugs which are known as peroxisome proliferator-activated receptor γ (PPARγ) ligands… (More)
  • table 1
  • figure 3
  • figure 3
  • figure 4
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
are agonists of the nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ), are effective at improving insulin… (More)
Is this relevant?
2011
2011
Thiazolidinediones are agonists for the peroxisome proliferator-activated receptor γ (PPARγ) and are effective agents for the… (More)
Is this relevant?